Part of his GLP-1 series, Krittanawong explains how PAD limits blood flow to the legs and causes pain when walking, and asks whether these drugs could help.
Recap by typeshit. Post by Chayakrit Krittanawong, MD, FACC, FAHA, FSCAI on X.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
The writer argues the headline merges separate stories, from FDA approval to an 80% visceral fat figure, and says the details don't hold together.
Loading…